 | • レポートコード：MRC2-11QY12402 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は内部神経調節のグローバル市場について調査・分析したレポートです。種類別（脊髄刺激、脳深部刺激療法、迷走神経刺激療法、仙骨神経刺激療法、胃電気刺激療法、その他）市場規模、用途別（疾病治療、研究開発）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別内部神経調節の競争状況、市場シェア ・世界の内部神経調節市場：種類別市場規模 2015年-2020年（脊髄刺激、脳深部刺激療法、迷走神経刺激療法、仙骨神経刺激療法、胃電気刺激療法、その他） ・世界の内部神経調節市場：種類別市場規模予測 2021年-2026年（脊髄刺激、脳深部刺激療法、迷走神経刺激療法、仙骨神経刺激療法、胃電気刺激療法、その他） ・世界の内部神経調節市場：用途別市場規模 2015年-2020年（疾病治療、研究開発） ・世界の内部神経調節市場：用途別市場規模予測 2021年-2026年（疾病治療、研究開発） ・北米の内部神経調節市場分析：米国、カナダ ・ヨーロッパの内部神経調節市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの内部神経調節市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の内部神経調節市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの内部神経調節市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Medtronic、Boston Scientific Corporation、Abbott、LivaNova、Synapse Biomedical、Nevro Corporation、NeuroSigma、NeuroPace、Neuronetics、BioControl Medical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Internal Neuromodulation Market
The global Internal Neuromodulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Internal Neuromodulation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Internal Neuromodulation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Internal Neuromodulation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Internal Neuromodulation market.
Global Internal Neuromodulation Scope and Market Size
Internal Neuromodulation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Internal Neuromodulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Gastric Electrical Stimulation
Others
Market segment by Application, split into
Disease Therapy
Research and Development
Based on regional and country-level analysis, the Internal Neuromodulation market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Internal Neuromodulation market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Medtronic
Boston Scientific Corporation
Abbott
LivaNova
Synapse Biomedical
Nevro Corporation
NeuroSigma
NeuroPace
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Internal Neuromodulation Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Vagus Nerve Stimulation
1.2.5 Sacral Nerve Stimulation
1.2.6 Gastric Electrical Stimulation
1.2.7 Others
1.3 Market by Application
1.3.1 Global Internal Neuromodulation Market Share by Application: 2020 VS 2026
1.3.2 Disease Therapy
1.3.3 Research and Development
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Internal Neuromodulation Market Perspective (2015-2026)
2.2 Global Internal Neuromodulation Growth Trends by Regions
2.2.1 Internal Neuromodulation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Internal Neuromodulation Historic Market Share by Regions (2015-2020)
2.2.3 Internal Neuromodulation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Internal Neuromodulation Players by Market Size
3.1.1 Global Top Internal Neuromodulation Players by Revenue (2015-2020)
3.1.2 Global Internal Neuromodulation Revenue Market Share by Players (2015-2020)
3.2 Global Internal Neuromodulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Internal Neuromodulation Revenue
3.4 Global Internal Neuromodulation Market Concentration Ratio
3.4.1 Global Internal Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Internal Neuromodulation Revenue in 2019
3.5 Key Players Internal Neuromodulation Area Served
3.6 Key Players Internal Neuromodulation Product Solution and Service
3.7 Date of Enter into Internal Neuromodulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Internal Neuromodulation Breakdown Data by Type (2015-2026)
4.1 Global Internal Neuromodulation Historic Market Size by Type (2015-2020)
4.2 Global Internal Neuromodulation Forecasted Market Size by Type (2021-2026)
5 Internal Neuromodulation Breakdown Data by Application (2015-2026)
5.1 Global Internal Neuromodulation Historic Market Size by Application (2015-2020)
5.2 Global Internal Neuromodulation Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Internal Neuromodulation Market Size (2015-2026)
6.2 North America Internal Neuromodulation Market Size by Type (2015-2020)
6.3 North America Internal Neuromodulation Market Size by Application (2015-2020)
6.4 North America Internal Neuromodulation Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Internal Neuromodulation Market Size (2015-2026)
7.2 Europe Internal Neuromodulation Market Size by Type (2015-2020)
7.3 Europe Internal Neuromodulation Market Size by Application (2015-2020)
7.4 Europe Internal Neuromodulation Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Internal Neuromodulation Market Size (2015-2026)
8.2 China Internal Neuromodulation Market Size by Type (2015-2020)
8.3 China Internal Neuromodulation Market Size by Application (2015-2020)
8.4 China Internal Neuromodulation Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Internal Neuromodulation Market Size (2015-2026)
9.2 Japan Internal Neuromodulation Market Size by Type (2015-2020)
9.3 Japan Internal Neuromodulation Market Size by Application (2015-2020)
9.4 Japan Internal Neuromodulation Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Internal Neuromodulation Market Size (2015-2026)
10.2 Southeast Asia Internal Neuromodulation Market Size by Type (2015-2020)
10.3 Southeast Asia Internal Neuromodulation Market Size by Application (2015-2020)
10.4 Southeast Asia Internal Neuromodulation Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Internal Neuromodulation Introduction
11.1.4 Medtronic Revenue in Internal Neuromodulation Business (2015-2020))
11.1.5 Medtronic Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Internal Neuromodulation Introduction
11.2.4 Boston Scientific Corporation Revenue in Internal Neuromodulation Business (2015-2020)
11.2.5 Boston Scientific Corporation Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Internal Neuromodulation Introduction
11.3.4 Abbott Revenue in Internal Neuromodulation Business (2015-2020)
11.3.5 Abbott Recent Development
11.4 LivaNova
11.4.1 LivaNova Company Details
11.4.2 LivaNova Business Overview
11.4.3 LivaNova Internal Neuromodulation Introduction
11.4.4 LivaNova Revenue in Internal Neuromodulation Business (2015-2020)
11.4.5 LivaNova Recent Development
11.5 Synapse Biomedical
11.5.1 Synapse Biomedical Company Details
11.5.2 Synapse Biomedical Business Overview
11.5.3 Synapse Biomedical Internal Neuromodulation Introduction
11.5.4 Synapse Biomedical Revenue in Internal Neuromodulation Business (2015-2020)
11.5.5 Synapse Biomedical Recent Development
11.6 Nevro Corporation
11.6.1 Nevro Corporation Company Details
11.6.2 Nevro Corporation Business Overview
11.6.3 Nevro Corporation Internal Neuromodulation Introduction
11.6.4 Nevro Corporation Revenue in Internal Neuromodulation Business (2015-2020)
11.6.5 Nevro Corporation Recent Development
11.7 NeuroSigma
11.7.1 NeuroSigma Company Details
11.7.2 NeuroSigma Business Overview
11.7.3 NeuroSigma Internal Neuromodulation Introduction
11.7.4 NeuroSigma Revenue in Internal Neuromodulation Business (2015-2020)
11.7.5 NeuroSigma Recent Development
11.8 NeuroPace
11.8.1 NeuroPace Company Details
11.8.2 NeuroPace Business Overview
11.8.3 NeuroPace Internal Neuromodulation Introduction
11.8.4 NeuroPace Revenue in Internal Neuromodulation Business (2015-2020)
11.8.5 NeuroPace Recent Development
11.9 Neuronetics
11.9.1 Neuronetics Company Details
11.9.2 Neuronetics Business Overview
11.9.3 Neuronetics Internal Neuromodulation Introduction
11.9.4 Neuronetics Revenue in Internal Neuromodulation Business (2015-2020)
11.9.5 Neuronetics Recent Development
11.10 BioControl Medical
11.10.1 BioControl Medical Company Details
11.10.2 BioControl Medical Business Overview
11.10.3 BioControl Medical Internal Neuromodulation Introduction
11.10.4 BioControl Medical Revenue in Internal Neuromodulation Business (2015-2020)
11.10.5 BioControl Medical Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Internal Neuromodulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Spinal Cord Stimulation
Table 4. Key Players of Deep Brain Stimulation
Table 5. Key Players of Vagus Nerve Stimulation
Table 6. Key Players of Sacral Nerve Stimulation
Table 7. Key Players of Gastric Electrical Stimulation
Table 8. Key Players of Others
Table 9. Global Internal Neuromodulation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Internal Neuromodulation Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Internal Neuromodulation Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Internal Neuromodulation Market Share by Regions (2015-2020)
Table 13. Global Internal Neuromodulation Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Internal Neuromodulation Market Share by Regions (2021-2026)
Table 15. Internal Neuromodulation Market Market Trends
Table 16. Internal Neuromodulation Market Drivers
Table 17. Internal Neuromodulation Market Challenges
Table 18. Internal Neuromodulation Market Restraints
Table 19. Global Internal Neuromodulation Revenue by Players (2015-2020) (US$ Million)
Table 20. Global Internal Neuromodulation Market Share by Players (2015-2020)
Table 21. Global Top Internal Neuromodulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Internal Neuromodulation as of 2019)
Table 22. Global Internal Neuromodulation by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Internal Neuromodulation Product Solution and Service
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Internal Neuromodulation Market Size by Type (2015-2020) (US$ Million)
Table 27. Global Internal Neuromodulation Market Size Share by Type (2015-2020)
Table 28. Global Internal Neuromodulation Revenue Market Share by Type (2021-2026)
Table 29. Global Internal Neuromodulation Market Size Share by Application (2015-2020)
Table 30. Global Internal Neuromodulation Market Size by Application (2015-2020) (US$ Million)
Table 31. Global Internal Neuromodulation Market Size Share by Application (2021-2026)
Table 32. North America Internal Neuromodulation Market Size by Type (2015-2020) (US$ Million)
Table 33. North America Internal Neuromodulation Market Share by Type (2015-2020)
Table 34. North America Internal Neuromodulation Market Size by Application (2015-2020) (US$ Million)
Table 35. North America Internal Neuromodulation Market Share by Application (2015-2020)
Table 36. North America Internal Neuromodulation Market Size by Country (US$ Million) (2015-2020)
Table 37. North America Internal Neuromodulation Market Share by Country (2015-2020)
Table 38. Europe Internal Neuromodulation Market Size by Type (2015-2020) (US$ Million)
Table 39. Europe Internal Neuromodulation Market Share by Type (2015-2020)
Table 40. Europe Internal Neuromodulation Market Size by Application (2015-2020) (US$ Million)
Table 41. Europe Internal Neuromodulation Market Share by Application (2015-2020)
Table 42. Europe Internal Neuromodulation Market Size by Country (US$ Million) (2015-2020)
Table 43. Europe Internal Neuromodulation Market Share by Country (2015-2020)
Table 44. China Internal Neuromodulation Market Size by Type (2015-2020) (US$ Million)
Table 45. China Internal Neuromodulation Market Share by Type (2015-2020)
Table 46. China Internal Neuromodulation Market Size by Application (2015-2020) (US$ Million)
Table 47. China Internal Neuromodulation Market Share by Application (2015-2020)
Table 48. China Internal Neuromodulation Market Size by Region (US$ Million) (2015-2020)
Table 49. China Internal Neuromodulation Market Share by Region (2015-2020)
Table 50. Japan Internal Neuromodulation Market Size by Type (2015-2020) (US$ Million)
Table 51. Japan Internal Neuromodulation Market Share by Type (2015-2020)
Table 52. Japan Internal Neuromodulation Market Size by Application (2015-2020) (US$ Million)
Table 53. Japan Internal Neuromodulation Market Share by Application (2015-2020)
Table 54. Japan Internal Neuromodulation Market Size by Country (US$ Million) (2015-2020)
Table 55. Japan Internal Neuromodulation Market Share by Country (2015-2020)
Table 56. Southeast Asia Internal Neuromodulation Market Size by Type (2015-2020) (US$ Million)
Table 57. Southeast Asia Internal Neuromodulation Market Share by Type (2015-2020)
Table 58. Southeast Asia Internal Neuromodulation Market Size by Application (2015-2020) (US$ Million)
Table 59. Southeast Asia Internal Neuromodulation Market Share by Application (2015-2020)
Table 60. Southeast Asia Internal Neuromodulation Market Size by Country (US$ Million) (2015-2020)
Table 61. Southeast Asia Internal Neuromodulation Market Share by Country (2015-2020)
Table 62. Medtronic Company Details
Table 63. Medtronic Business Overview
Table 64. Medtronic Product
Table 65. Medtronic Revenue in Internal Neuromodulation Business (2015-2020) (US$ Million)
Table 66. Medtronic Recent Development
Table 67. Boston Scientific Corporation Company Details
Table 68. Boston Scientific Corporation Business Overview
Table 69. Boston Scientific Corporation Product
Table 70. Boston Scientific Corporation Revenue in Internal Neuromodulation Business (2015-2020) (US$ Million)
Table 71. Boston Scientific Corporation Recent Development
Table 72. Abbott Company Details
Table 73. Abbott Business Overview
Table 74. Abbott Product
Table 75. Abbott Revenue in Internal Neuromodulation Business (2015-2020) (US$ Million)
Table 76. Abbott Recent Development
Table 77. LivaNova Company Details
Table 78. LivaNova Business Overview
Table 79. LivaNova Product
Table 80. LivaNova Revenue in Internal Neuromodulation Business (2015-2020) (US$ Million)
Table 81. LivaNova Recent Development
Table 82. Synapse Biomedical Company Details
Table 83. Synapse Biomedical Business Overview
Table 84. Synapse Biomedical Product
Table 85. Synapse Biomedical Revenue in Internal Neuromodulation Business (2015-2020) (US$ Million)
Table 86. Synapse Biomedical Recent Development
Table 87. Nevro Corporation Company Details
Table 88. Nevro Corporation Business Overview
Table 89. Nevro Corporation Product
Table 90. Nevro Corporation Revenue in Internal Neuromodulation Business (2015-2020) (US$ Million)
Table 91. Nevro Corporation Recent Development
Table 92. NeuroSigma Company Details
Table 93. NeuroSigma Business Overview
Table 94. NeuroSigma Product
Table 95. NeuroSigma Revenue in Internal Neuromodulation Business (2015-2020) (US$ Million)
Table 96. NeuroSigma Recent Development
Table 97. NeuroPace Business Overview
Table 98. NeuroPace Product
Table 99. NeuroPace Company Details
Table 100. NeuroPace Revenue in Internal Neuromodulation Business (2015-2020) (US$ Million)
Table 101. NeuroPace Recent Development
Table 102. Neuronetics Company Details
Table 103. Neuronetics Business Overview
Table 104. Neuronetics Product
Table 105. Neuronetics Revenue in Internal Neuromodulation Business (2015-2020) (US$ Million)
Table 106. Neuronetics Recent Development
Table 107. BioControl Medical Company Details
Table 108. BioControl Medical Business Overview
Table 109. BioControl Medical Product
Table 110. BioControl Medical Revenue in Internal Neuromodulation Business (2015-2020) (US$ Million)
Table 111. BioControl Medical Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Internal Neuromodulation Market Share by Type: 2020 VS 2026
Figure 2. Spinal Cord Stimulation Features
Figure 3. Deep Brain Stimulation Features
Figure 4. Vagus Nerve Stimulation Features
Figure 5. Sacral Nerve Stimulation Features
Figure 6. Gastric Electrical Stimulation Features
Figure 7. Others Features
Figure 8. Global Internal Neuromodulation Market Share by Application: 2020 VS 2026
Figure 9. Disease Therapy Case Studies
Figure 10. Research and Development Case Studies
Figure 11. Internal Neuromodulation Report Years Considered
Figure 12. Global Internal Neuromodulation Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Internal Neuromodulation Market Share by Regions: 2020 VS 2026
Figure 14. Global Internal Neuromodulation Market Share by Regions (2021-2026)
Figure 15. Global Internal Neuromodulation Market Share by Players in 2019
Figure 16. Global Top Internal Neuromodulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Internal Neuromodulation as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Internal Neuromodulation Revenue in 2019
Figure 18. North America Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Internal Neuromodulation Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Medtronic Revenue Growth Rate in Internal Neuromodulation Business (2015-2020)
Figure 46. Boston Scientific Corporation Revenue Growth Rate in Internal Neuromodulation Business (2015-2020)
Figure 47. Abbott Revenue Growth Rate in Internal Neuromodulation Business (2015-2020)
Figure 48. LivaNova Revenue Growth Rate in Internal Neuromodulation Business (2015-2020)
Figure 49. Synapse Biomedical Revenue Growth Rate in Internal Neuromodulation Business (2015-2020)
Figure 50. Nevro Corporation Revenue Growth Rate in Internal Neuromodulation Business (2015-2020)
Figure 51. NeuroSigma Revenue Growth Rate in Internal Neuromodulation Business (2015-2020)
Figure 52. NeuroPace Revenue Growth Rate in Internal Neuromodulation Business (2015-2020)
Figure 53. Neuronetics Revenue Growth Rate in Internal Neuromodulation Business (2015-2020)
Figure 54. BioControl Medical Revenue Growth Rate in Internal Neuromodulation Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
仙骨神経刺激の世界市場（～2026年） Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor. The external SNS device is one of the fastest growing product s…- 脳深部刺激療法（DBS）の世界市場（～2026年） Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the tre…
- 脊髄刺激システムの世界市場（～2026年） The spinal cord stimulation system is also known as a neurostimulation system which provides the therapeutic treatment of the chronic back, neck and extremity pain. The increasing prevalence of chronic and neuropathic pain disorders and the increasing technological advancements to the spinal cord st…
- 外部神経調節の世界市場（～2026年） Market Analysis and Insights: Global External Neuromodulation Market The global External Neuromodulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global External Neuromodulation Scope and Market Size External Neuromodu…
- 神経調節の世界市場（～2026年） Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incid…